Neuroendocrine Tumor — Trials

Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

805 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–100 of 149 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04954820	Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET(ReLUTH)	recruiting	Phase 2	146	Institut du Cancer de Montpellier - Val d'AurelleOTHER	1	Jun 4, 2026	clinicaltrials
NCT06607692	Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).(LUPARPED)	recruiting	Phase 1 / Phase 2	25	Fundación de investigación HM